BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+16.15%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.4B
AUM Growth
+$11.4B
(-5.2%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-9.36%
Top 10 Holdings %
Top 10 Hldgs %
75.13%
Holding
140
New
10
Increased
24
Reduced
17
Closed
12
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.18B |
| 2 |
AbbVie
ABBV
|
$966M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$96.5M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$50.5M |
| 5 |
ATYR
aTyr Pharma
ATYR
|
$43.2M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$2.31B |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$1.14B |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$44.8M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$17M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$14.4M |
Sector Composition
| 1 | Healthcare | 72.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sangamo Therapeutics
SGMO
$161M
| $35.8M | 0.31% |
3,230,932
+1,826,388
| +130% | +$20.3M |
|
|
IMGN
27
DELISTED
Immunogen Inc
IMGN
| $33.4M | 0.29% |
2,320,424
+1,320,928
| +132% | +$19M |
|
28
TG Therapeutics
TGTX
$5.03B
| $33.2M | 0.29% |
2,003,991
-46,322
| -2% | -$768K |
|
|
PGNX
29
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $32.5M | 0.28% |
4,350,808
| – | – |
|
30
Catalyst Pharmaceutical
CPRX
$2.42B
| $30.3M | 0.27% |
7,335,692
-229,770
| -3% | -$949K |
|
31
Gilead Sciences
GILD
$140B
| $29.3M | 0.26% |
249,995
| – | – |
|
|
KYTH
32
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $29.2M | 0.26% |
387,741
+33,476
| +9% | +$2.52M |
|
33
Neurocrine Biosciences
NBIX
$13.5B
| $25.9M | 0.23% |
542,236
| – | – |
|
|
ACGN
34
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $25.9M | 0.23% |
51,308
+40
| +0.1% | +$20.2K |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| $25.4M | 0.22% |
11,665
+349
| +3% | +$761K |
|
|
DSCI
36
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $24.8M | 0.22% |
3,457,841
| – | – |
|
|
ACOR
37
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $24.6M | 0.22% |
6,158
| – | – |
|
38
Novavax
NVAX
$1.2B
| $21.7M | 0.19% |
97,284
| – | – |
|
|
FOMX
39
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $21M | 0.18% |
2,046,967
+225,000
| +12% | +$2.31M |
|
40
Xencor
XNCR
$594M
| $19.2M | 0.17% |
872,072
| – | – |
|
41
Galapagos
GLPG
$2.06B
| $19M | 0.17% |
+369,276
| New | +$19M |
|
|
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
| $17.8M | 0.16% |
202,630
| – | – |
|
43
Omeros
OMER
$284M
| $17.4M | 0.15% |
964,621
+327,175
| +51% | +$5.89M |
|
|
ZGNX
44
DELISTED
Zogenix, Inc.
ZGNX
| $16.8M | 0.15% |
1,253,571
+966,263
| +336% | +$13M |
|
45
Iovance Biotherapeutics
IOVA
$800M
| $16.7M | 0.15% |
1,817,429
+492,429
| +37% | +$4.52M |
|
46
ProQR Therapeutics
PRQR
$256M
| $16.5M | 0.14% |
988,299
+588,299
| +147% | +$9.81M |
|
|
RPRX
47
DELISTED
Repros Therapeutics Inc.
RPRX
| $14M | 0.12% |
1,955,944
-44,056
| -2% | -$315K |
|
|
ACHN
48
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $13.5M | 0.12% |
1,523,739
+1,309,502
| +611% | +$11.6M |
|
49
Ultragenyx Pharmaceutical
RARE
$3.04B
| $12.7M | 0.11% |
123,894
-25,000
| -17% | -$2.56M |
|
|
MTEM
50
DELISTED
Molecular Templates, Inc.
MTEM
| $11.8M | 0.1% |
17,730
| – | – |
|